Enrichment of small genomic duplications spanning the GJA5 gene in cohorts with tetralogy of Fallot and cardiac abnormalities in mice with a targeted GJA5 deletion imply that dosage variations of GJA5 contribute to CHD [52]. Here, GJA5 is linked to coronary artery disorder.